Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update on ublituximab for relapsed or refractory B-cell non-Hodgkin lymphoma completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL [Phase 2]
Phase 2 trial update investigating zanubrutinib in combination with R-CHOP for newly diagnosed untreated non-GCB/ABC diffuse large B-cell ly…
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 [Phase 4]
Phase 4 clinical trial update for a B-cell mature non-Hodgkin lymphoma treatment protocol in children and adolescents; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating multiple dose regimens of MT-3724 with gemcitabine and oxaliplatin in relapsed/refractory diffuse large B-cell lymp…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003) [Phase 2]
Phase 2 trial investigating multiple dose regimens of MT-3724 with lenalidomide in relapsed/refractory B-cell non-Hodgkin lymphoma; study te…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial update on secondary prophylaxis in Non-Hodgkin Lymphoma and chemotherapy-induced thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL [Phase 1, Phase 2]
Phase 1/2 trial evaluating KRT-232 in combination with acalabrutinib for relapsed/refractory DLBCL and CLL; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A phase 1/2 study evaluating pembrolizumab (MK-3475) alone or with copanlisib in relapsed or refractory NK/T-cell non-Hodgkin lymphoma; the …
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection [Phase 2]
A Phase 2 trial evaluated EPOCH chemotherapy with Rituximab for HIV-associated non-Hodgkin lymphoma, including diffuse large B-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma [Phase 2]
Phase 2 trial update for therapy in untreated DLBCL patients across risk groups; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial [Phase 2]
A multicenter randomized Phase II trial evaluating treatment options for diffuse large B-cell lymphoma in vulnerable or frail elderly patien…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating laboratory-treated T cells in relapsed or refractory B-cell malignancies and acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment [Phase 1, Phase 2]
Clinical trial update on clofarabine in relapsed or refractory T-cell or NK-cell non-Hodgkin's lymphoma (Phase 1/2) completed with posted re…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia [Phase 4]
Phase 4 clinical trial evaluating rasburicase for prevention and treatment of hyperuricemia in pediatric patients with non-Hodgkin's lymphom…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial investigating bendamustine and rituximab in combination with copanlisib for chronic lymphocytic leukemia or small lymphocytic …
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating chidamide, decitabine, and immune checkpoint inhibitors in relapsed/refractory non-Hodgkin lymphoma an…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies [Phase 3]
Phase 3 clinical trial update on stem cell transplantation from partially HLA-m matched related donors for hematologic malignancies; trial c…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the combination of ibrutinib with methotrexate and temozolomide for newly diagnosed primary central nervou…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update for a CAR-T therapy targeting Igβ in relapsed/refractory B-cell non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial update for ONC201 in relapsed/refractory non-Hodgkin's lymphoma, including phase 1 and phase 2 cohorts; study status terminat…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study [Phase 4]
Phase 4 clinical trial update for Ultrafast Truxima infusion in Non-Hodgkin's Lymphoma (Txagorapid Study).
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma [Phase 2]
Phase 2 trial update for GOAL: GA101 plus pixantrone in relapsed aggressive lymphoma (non-Hodgkin lymphoma).
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma [Phase 2]
Phase II study evaluating zanubrutinib with lenalidomide and R-CHOP as first-line therapy for diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of SRA737 in advanced solid tumors and non-Hodgkin's lymphoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 study evaluating chimauranib in combination with chidamide for relapsed/refractory non-Hodgkin's lymphoma has completed.